Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
Authors
Chadi, SMalcomson, Lee
Ensor, J
Riley, R
Vaccaro, C
Rossi, G
Daniels, I
Smart, N
Osborne, M
Beets, G
Maas, M
Bitterman, D
Du, K
Gollins, S
Sun Myint, A
Smith, F
Saunders, Mark P
Scott, N
O'Dwyer, Sarah T
de Castro Araujo, R
Valadao, M
Lopes, A
Hsiao, C
Lai, C
Smith, R
Paulson, E
Appelt, A
Jakobsen, A
Wexner, S
Habr-Gama, A
Sao Julião, G
Perez, R
Renehan, Andrew G
Affiliation
Division of Surgical Oncology and General Surgery, Princess Margaret Hospital and University Health Network, University of Toronto, Toronto, ON, CanadaIssue Date
2018-10-11
Metadata
Show full item recordAbstract
In patients with rectal cancer who achieve clinical complete response after neoadjuvant chemoradiotherapy, watch and wait is a novel management strategy with potential to avoid major surgery. Study-level meta-analyses have reported wide variation in the proportion of patients with local regrowth. We did an individual participant data meta-analysis to investigate factors affecting occurrence of local regrowth.Citation
Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. 2018 Lancet Gastroenterol HepatolJournal
The Lancet. Gastroenterology & HepatologyDOI
10.1016/S2468-1253(18)30301-7PubMed ID
30318451Type
ArticleLanguage
enISSN
2468-1253ae974a485f413a2113503eed53cd6c53
10.1016/S2468-1253(18)30301-7
Scopus Count
Collections
Related articles
- A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
- Authors: Dossa F, Chesney TR, Acuna SA, Baxter NN
- Issue date: 2017 Jul
- Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
- Authors: Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP, Wilson MS, Scott N, O'Dwyer ST
- Issue date: 2016 Feb
- Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
- Authors: Fernandez LM, São Julião GP, Figueiredo NL, Beets GL, van der Valk MJM, Bahadoer RR, Hilling DE, Meershoek-Klein Kranenbarg E, Roodvoets AGH, Renehan AG, van de Velde CJH, Habr-Gama A, Perez RO, International Watch & Wait Database Consortium
- Issue date: 2021 Jan
- [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
- Authors: Li SJ, Wang L, Zhang XY, Li YH, Li ZW, Wu Q, Sun YS, Wu AW
- Issue date: 2019 Jul 25
- Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
- Authors: Sposato LA, Lam Y, Karapetis C, Vatandoust S, Roy A, Hakendorf P, Dwyer A, de Fontgalland D, Hollington P, Wattchow D
- Issue date: 2018 Dec